Please login to the form below

Not currently logged in
Email:
Password:

Amitiza

This page shows the latest Amitiza news and features for those working in and with pharma, biotech and healthcare.

Lilly’s Efient and Sucampo's Amitiza win NICE backing

Lilly’s Efient and Sucampo's Amitiza win NICE backing

Lilly’ s Efient and Sucampo's Amitiza win NICE backing. Blood clot and constipation drugs recommended for NHS use. ... The Amitiza recommendation follows earlier draft guidance published in June that determined the drug was a cost effective treatment

Latest news

  • NICE backs constipation treatment NICE backs constipation treatment

    NICE backs constipation treatment. Sucampo’ s Amitiza set for NHS use in England and Wales. ... Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance.

  • NICE backs constipation treatment NICE backs constipation treatment

    NICE backs constipation treatment. Sucampo’ s Amitiza set for NHS use in England and Wales. ... Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance.

  • AZ drug for opioid constipation starts FDA review AZ drug for opioid constipation starts FDA review

    AZ drug for opioid constipation starts FDA review. Naloxegol on course to compete with Takeda’ s Amitiza. ... Sucampo reported Amitiza sales of a little over $80m in 2012 but that product is also tipped to reach $200m.

  • Sucampo-Takeda to file for US approval of Amitiza as OBD treatment

    It is estimated that 4.5m patients in the US suffer from OBD, so extending Amitiza's indications to include this use could dramatically increase sales. ... added. Sucampo is in the final stages of an arbitration process seeking to revise the terms of its

  • An unexpected turn

    Amitiza (Takeda Pharmaceuticals). Irritable Bowel Syndrome. US. Mycophenolate mofetil (Cellcept; Roche) is an immunosupressant commonly used for treating and preventing transplant rejection.

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Congress Effectiveness Management
Maximising the ROI of scientific meetings...
Shanghai
Biopharma's Future: Made in China
The world’s second biggest pharma market is entering a new growth phase – but meeting its needs takes investment and expertise...
Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...

Infographics